SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (2670)5/3/1997 1:52:00 PM
From: Elllk   of 4342
 
Rick

I am already on record saying that I hope the prln has at least learned enough to suggest a roll out date that they know they can meet or beat. I also (no inside info here) think it could very well be a labelling issue. Labelling issues often result in delays of good products. I have some concern that even if it is a labelling issue it could result in further delays. They can be thorny issues and I just hope that if it is 'only' a labelling issue it is handled well and quickly.

I also have posted that if there are FDA concerns about labelling or something else, as long as there is a good chance of those concerns being resolved fairly quickly, it is much better to not release a product somewhere else that might have substance, format or labelling issues that would be problematic to the FDA or some other overseer (ie European agaencies?). It is much better to have everything resolved to be able to bring it out in the same way in all the markets at once, I think.

Larry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News